More negative headlines for Pharma highlighting the importance of transparency
The BMJ this week published a re-analysis of infamous paroxetine trial – Study 329. The re-analysis found differing results, and came to different conclusions versus the original manuscript article. The … Continue Reading More negative headlines for Pharma highlighting the importance of transparency